Biologics
provides a patient-focused platform for managing the financial, emotional and physical burdens of cancer treatment... Read moreBiologics
provides a patient-focused platform for managing the financial, emotional and physical burdens of cancer treatment... Read more
CEO
Add
News
Oct 02, 2019
BioPortfolio
Biologics: NMPA Approves IND Application for CT103A a Fullyhuman BCMA CART for the Treatment of RelapsedRefractory Multiple Myeloma Codeveloped by IASO BIO and Innovent Biologics
Aug 21, 2019
BioSpace
Biologics: ROZLYTREK (entrectinib), FDA Approved for Hard-to-Treat NTRK Fusion-Positive Tumors, Available at Biologics by McKesson
Mar 21, 2019
BioPortfolio
Biologics: Biologics by McKesson Expands Specialty Pharmacy Capabilities to Serve Patients with Rare and Complex Conditions
Dec 27, 2018
FinanzNachrichten
Biologics: Innovent, Lilly Co-developed Tyvyt Gets China's NMPA Approval For CHL
Dec 07, 2018
PharmiWeb
Biologics: XOSPATA® (gilteritinib) Available at Biologics by McKesson
Nov 21, 2018
BioPortfolio
Biologics: Biologics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27092018 Prices from USD $250
Sep 26, 2018
BioPortfolio
Biologics: COPIKTRA duvelisib Available for Order at Biologics Inc.
Jul 31, 2018
BioPortfolio
Biologics: Biologics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250
May 29, 2018
4-traders
Biologics: McKesson : TAVALISSE (fostamatinib disodium hexahydrate) Approved by FDA, Available for Order at Biologics, Inc.
Mar 26, 2018
BioPortfolio
Biologics: Biologics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27022018 Prices from USD $250
Biologics Competitors
1
2
3
4
5
6
7
8
9
10